Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

In a sea of green, there are plenty of cheap stocks still out there. The post 7 beaten-up ASX shares with 'strong balance ...

Despite a challenging year for lithium in 2024, optimism abounds for the sector in the new year, according to Killian Charles ...

While tech stocks have taken a hit from the DeepSeek-related news, uranium stocks are experiencing a much steeper decline, ...